BANK OF AMERICA CORP /DE/ - ANNOVIS BIO INC ownership

ANNOVIS BIO INC's ticker is ANVS and the CUSIP is 03615A108. A total of 27 filers reported holding ANNOVIS BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ANNOVIS BIO INC
ValueSharesWeighting
Q3 2023$1,680
-33.6%
1770.0%0.00%
Q2 2023$2,529
-82.5%
177
-83.5%
0.00%
Q4 2022$14,423
-46.6%
1,074
-46.1%
0.00%
Q3 2022$27,000
-72.7%
1,991
-77.0%
0.00%
Q2 2022$99,000
+3.1%
8,662
+20.8%
0.00%
Q1 2022$96,000
-55.1%
7,168
-41.0%
0.00%
Q4 2021$214,000
-61.4%
12,151
-30.5%
0.00%
Q3 2021$555,00017,478
+124742.9%
0.00%
Q1 2021$0
-100.0%
14
-98.9%
0.00%
Q1 2020$4,0001,2250.00%
Other shareholders
ANNOVIS BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 463,797$3,497,0001.42%
Worth Venture Partners, LLC 119,538$901,0000.71%
Lokken Investment Group LLC 32,211$243,0000.22%
Sterling Investment Advisors, Ltd. 50,588$381,0000.13%
Modera Wealth Management, LLC 43,846$331,0000.03%
Cannell & Co. 10,000$75,0000.00%
Sowell Financial Services LLC 1,529$12,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 14,286$108,0000.00%
BROWN ADVISORY INC 14,942$113,0000.00%
View complete list of ANNOVIS BIO INC shareholders